Home » Topics » Disease categories and therapies » Respiratory

Respiratory
RSS

Research at Kowa leads to potent inhibitors of IgE antibody production

May 21, 1998

Merck KGaA synthesizes new series of PDE IV inhibitors

May 21, 1998

Celgene claims agents for reducing cytokine levels

May 20, 1998

New PDE IV inhibitors from Euroceltique

May 19, 1998

Rhone-Poulenc Rorer submits NDA for ebastine in U.S.

May 18, 1998

RPR scientists identify new nonpeptide RANTES antagonist

May 14, 1998

Banyu describes antimuscarinic piperidines with bronchodilating effects

May 14, 1998

CytoMed evaluates CMI-977 in phase I for asthma

May 13, 1998

Transcend Therapeutics announces decision to terminate Procysteine phase III trial

May 13, 1998

IRL-3630: a bifunctional ET antagonist for respiratory ailments

May 12, 1998

Popular Stories

Today's news in brief
BioWorld
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
New mechanism of action identified for QC-6352
BioWorld Science
QC-6352 is a small molecule developed to inhibit the histone demethylase 4 (KDM4) that has shown potent antitumoral activity and which has a derivative named...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...